vs
Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
Community Healthcare Trust Inc is the larger business by last-quarter revenue ($31.5M vs $31.1M, roughly 1.0× LIFECORE BIOMEDICAL, INC. \DE\). Community Healthcare Trust Inc runs the higher net margin — 8.1% vs -32.1%, a 40.2% gap on every dollar of revenue. On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (4.8% vs -4.5%). Over the past eight quarters, Community Healthcare Trust Inc's revenue compounded faster (7.0% CAGR vs -0.1%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
CHCT vs LFCR — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $31.5M | $31.1M |
| Net Profit | $2.5M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | — | -9.9% |
| Net Margin | 8.1% | -32.1% |
| Revenue YoY | 4.8% | -4.5% |
| Net Profit YoY | 60.2% | -52.0% |
| EPS (diluted) | — | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $31.5M | — | ||
| Q4 25 | $30.9M | — | ||
| Q3 25 | $31.1M | $31.1M | ||
| Q2 25 | $29.1M | — | ||
| Q1 25 | $30.1M | $35.2M | ||
| Q4 24 | $29.3M | $32.6M | ||
| Q3 24 | $29.6M | $24.7M | ||
| Q2 24 | $27.5M | — |
| Q1 26 | $2.5M | — | ||
| Q4 25 | $14.4M | — | ||
| Q3 25 | $1.6M | $-10.0M | ||
| Q2 25 | $-12.6M | — | ||
| Q1 25 | $1.6M | $-14.8M | ||
| Q4 24 | $1.8M | $-6.6M | ||
| Q3 24 | $1.7M | $-16.2M | ||
| Q2 24 | $-10.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | — | -6.0% | ||
| Q3 24 | — | -46.9% | ||
| Q2 24 | — | — |
| Q1 26 | 8.1% | — | ||
| Q4 25 | 46.6% | — | ||
| Q3 25 | 5.3% | -32.1% | ||
| Q2 25 | -43.2% | — | ||
| Q1 25 | 5.3% | -42.0% | ||
| Q4 24 | 6.3% | -20.2% | ||
| Q3 24 | 5.9% | -65.7% | ||
| Q2 24 | -37.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | $0.52 | — | ||
| Q3 25 | $0.03 | $-0.29 | ||
| Q2 25 | $-0.50 | — | ||
| Q1 25 | $0.03 | $-0.47 | ||
| Q4 24 | $0.04 | $-0.25 | ||
| Q3 24 | $0.04 | $-0.53 | ||
| Q2 24 | $-0.42 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.6M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $421.3M | $-10.5M |
| Total Assets | $1.0B | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $2.6M | — | ||
| Q4 25 | $3.3M | — | ||
| Q3 25 | $3.4M | $18.9M | ||
| Q2 25 | $4.9M | — | ||
| Q1 25 | $2.3M | $5.4M | ||
| Q4 24 | $4.4M | $9.5M | ||
| Q3 24 | $2.8M | — | ||
| Q2 24 | $734.0K | — |
| Q1 26 | — | — | ||
| Q4 25 | $532.2M | — | ||
| Q3 25 | $530.1M | $136.0M | ||
| Q2 25 | $500.1M | — | ||
| Q1 25 | $496.0M | $124.9M | ||
| Q4 24 | $486.0M | $111.3M | ||
| Q3 24 | $473.7M | $106.3M | ||
| Q2 24 | $457.6M | — |
| Q1 26 | $421.3M | — | ||
| Q4 25 | $429.4M | — | ||
| Q3 25 | $426.8M | $-10.5M | ||
| Q2 25 | $437.8M | — | ||
| Q1 25 | $461.3M | $2.2M | ||
| Q4 24 | $476.0M | $15.4M | ||
| Q3 24 | $477.2M | $-3.9M | ||
| Q2 24 | $497.8M | — |
| Q1 26 | $1.0B | — | ||
| Q4 25 | $990.8M | — | ||
| Q3 25 | $987.3M | $235.2M | ||
| Q2 25 | $966.3M | — | ||
| Q1 25 | $985.1M | $237.7M | ||
| Q4 24 | $992.6M | $255.4M | ||
| Q3 24 | $981.8M | $246.8M | ||
| Q2 24 | $983.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.24× | — | ||
| Q3 25 | 1.24× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | 56.05× | ||
| Q4 24 | 1.02× | 7.20× | ||
| Q3 24 | 0.99× | — | ||
| Q2 24 | 0.92× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.8M |
| Free Cash FlowOCF − Capex | — | $25.0K |
| FCF MarginFCF / Revenue | — | 0.1% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $56.4M | — | ||
| Q3 25 | $12.7M | $1.8M | ||
| Q2 25 | $13.8M | — | ||
| Q1 25 | $14.4M | $1.2M | ||
| Q4 24 | $58.9M | $-6.1M | ||
| Q3 24 | $13.8M | $-613.0K | ||
| Q2 24 | $16.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $35.9M | — | ||
| Q3 25 | $7.6M | $25.0K | ||
| Q2 25 | $9.6M | — | ||
| Q1 25 | $9.7M | $-4.3M | ||
| Q4 24 | $34.2M | $-8.6M | ||
| Q3 24 | $6.7M | $-4.0M | ||
| Q2 24 | $9.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | 116.0% | — | ||
| Q3 25 | 24.6% | 0.1% | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 32.3% | -12.1% | ||
| Q4 24 | 116.9% | -26.3% | ||
| Q3 24 | 22.5% | -16.3% | ||
| Q2 24 | 34.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 66.3% | — | ||
| Q3 25 | 16.3% | 5.6% | ||
| Q2 25 | 14.5% | — | ||
| Q1 25 | 15.6% | 15.5% | ||
| Q4 24 | 84.1% | 7.5% | ||
| Q3 24 | 24.2% | 13.9% | ||
| Q2 24 | 26.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.91× | — | ||
| Q3 25 | 7.76× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 9.06× | — | ||
| Q4 24 | 32.14× | — | ||
| Q3 24 | 7.92× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CHCT
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
